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Objective: To describe how demographic characteristics and knowledge of cervical cancer influence screening
acceptance among women living in Dar es Salaam, Tanzania.
Methods: Multistage cluster sampling was carried out in 45 randomly selected streets in Dar es Salaam. Women
between the ages of 25–59 who lived in the sampled streets were invited to a cervical cancer screening; 804
women accepted and 313 rejected the invitation. Information on demographic characteristics and knowledge of
cervical cancer were obtained through structured questionnaire interviews.
Results: Women aged 35–44 and women aged 45–59 had increased ORs of 3.52 and 7.09, respectively, for
accepting screening. Increased accepting rates were also found among single women (OR 2.43) and among
women who had attended primary or secondary school (ORs of 1.81 and 1.94). Women who had 0–2 children were
also more prone to accept screening in comparison with women who had five or more children (OR 3.21). Finally,
knowledge of cervical cancer and awareness of the existing screening program were also associated with increased
acceptance rates (ORs of 5.90 and 4.20).
Conclusion: There are identifiable subgroups where cervical cancer screening can be increased in Dar es Salaam.
Special attention should be paid to women of low education and women of high parity. In addition, knowledge
and awareness raising campaigns that goes hand in hand with culturally acceptable screening services will likely
lead to an increased uptake of cervical cancer screening.
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With an estimated 500,000 new cases and the cause of
273,000 deaths each year, cervical cancer is one of the
most prevalent and deadly female cancers worldwide.
The vast majority of cervical cancer cases (99,7%) are
linked to genital infection with human papillomavirus
(HPV) [1], a common virus that is sexually transmitted
[2]. Sub-Saharan Africa is by far the most affected re-
gion, accounting for 80% of the new cases and 85% of
the deaths from cervical cancer worldwide [3]. In devel-
oped countries with well-established screening pro-
grams, the incidences of cervical cancer have been* Correspondence: vrasch@health.sdu.dk
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reproduction in any medium, provided the orreduced by 70-90% [4,5]. In contrast, in developing
countries where access to screening services for cervical
cancer is often limited or nonexistent the incidence of
women affected by the disease continues to exist at high
levels [6-8].
In the developed world, the introduction of pap smear
as a screening test modality has led to a reduction of the
burden of cervical cancer. However, there are several
factors that, in addition to the availability of a screening
test, contribute to reducing the burden of cervical can-
cer. These include prevalence rates of HPV, effective
screening strategies, availability of facilities for diagnostic
follow up and prompt treatment of detected lesions. The
participation rate in cervical cancer screening is of
utmost importance for the effectiveness of a cervical
cancer screening program [9,10]. The adoption of pap
smear as a screening approach in the developing worldLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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trained cytotechnologists, cytology laboratories and inef-
ficient health systems [5,11]. In an effort to curb the
burden of cervical cancer in developing countries, the
World Health Organization (WHO) and the Inter-
national Agency for Research on Cancer (IARC) have
established cervical cancer screening programs by adopt-
ing an alternative screening method based on visual in-
spection with acetic acid (VIA) [12,13]. The VIA test has
proven to have similar sensitivity to that of cytology but
lower specificity and positive predictive value when eval-
uated in clinical research settings [14]. Experiences from
Tanzania indicate that when VIA test is introduced for
wide-spread routine use it may be at the cost of poorer
test performance [15].
When focusing on Tanzania, cervical cancer is, with
an estimated incidence rate of 68.6/100,000, the leading
cause of cancer and cancer-related deaths [16]. This inci-
dence rate is also high when compared to other sub-
Saharan African countries. At Tanzania’s only cancer
center, the Ocean Road Cancer Institute in Dar es
Salaam, 80% of cervical cancer patients have already pro-
gressed to a late, incurable stage by the time women
present themselves for medical care. Acknowledging the
increasing burden of the disease, a cervical cancer
screening program based on VIA test was established in
Dar es Salaam with support from WHO, IARC and the
International Network for Cancer Treatment and Re-
search in 2002. An evaluation of the program documen-
ted that the VIA test was effective as a screening test for
cervical cancer prevention and it was decided to offer
VIA testing for routine use [17]. The routine program is
targeting approximately 500,000 women living in Dar es
Salaam. Five years after project implementation, screen-
ing attendance was evaluated and it was found that only
4% of the target population had been screened. To ad-
dress the poor screening coverage, the cervical cancer
screening program in Tanzania has undergone several
iterations in recent years. Despite these efforts, the avail-
able screening resources are still not utilized by the vast
majority of women living in Dar es Salaam [18].
To inform the strategy for future scale-up of cervical
cancer screening and better reach women with cervical
cancer screening services, this paper focuses on a group
of women who were invited to attend the cervical cancer
screening program in Dar es Salaam and describes how
demographic characteristics and knowledge of cervical
cancer are associated with screening acceptance.
Methods
Study setting
The study was carried out among women aged between
25–59 years living in Dar es Salaam, Tanzania. Based on
the 2002 Population and Housing Census, Dar es Salaamhad 2,487,288 inhabitants, of whom 700,000 were women
in a reproductive age group. Ninety-five percent of the
residents are engaged in the non-formal sector and the
rest are formally employed. Women are mainly involved
in the domestic sphere and the literacy level is more than
50%. The city is divided into three municipal councils:
Kinondoni, Ilala and Temeke. The population is served by
one national hospital, three municipal hospitals and a
number of private hospitals and dispensaries. Additionally,
Dar es Salaam has the only centre for specialized cancer
care in Tanzania, Ocean Road Cancer Institute. The study
population comprised of a group of women from the gen-
eral population who were aged 25–59 years and who had
never attended cervical cancer screening (Figure 1).
Study population
To identify a representative group of women, multistage
cluster sampling was performed where three wards from
each of the three municipals in Dar es Salaam were
randomly selected. In all 6063 women in the age group
25–59 years were living in the nine sampled wards. Five
streets were subsequently selected randomly from each
of the wards. Two strategies were employed to recruit
the study participants. The first approach was home vis-
its performed by the principal investigator and research
assistants with help from the community leaders from
the respective streets in Kinondoni municipal. In all 431
women were considered eligible for the study, 35 of these
women were not included in the study since they were
either not at home when attempted visited or stated they
had previously attended screening. The remaining
396 women were interviewed and afterwards provided
with health education on cervical cancer and invited to
attend screening at Ocean Road Cancer Institute. Only
83 women accepted the invitation. The second approach
relied on combination of outreach services and aware-
ness raising campaigns. This approach was used in the
two remaining municipals, Temeke and Ilala. Through
campaigns that were conducted by means of megaphones
in the sampled streets, women were provided with health
information and invited to attend outreach screening
for cervical cancer at the municipal hospitals. In all,
807 women showed up for screening, 86 of these women
were excluded from the study sample because they were
either living outside the selected streets (n=41) or had
previously attended screening (n=45).
Data collection and analyses
Structured questionnaire interviews focusing on demo-
graphic characteristics and knowledge and awareness of
cervical cancer were performed among the 1117 women
who were either visited at home and invited to attend
screening or had attended screening after awareness rais-
ing campaigns. To assess how demographic characteristics
Figure 1 Schematic view of the study population.
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age, marital status, educational level and number of chil-
dren between the 804 women who accepted screening
after either home visit or awareness raising campaigns and
the 313 women who did not accept the screening invita-
tion. The association between screening acceptance and
knowledge and awareness of cervical cancer was deter-
mined through a comparison of the 83 women from the
home visit group who accepted screening and the 313
women from the home visit group who did not accept the
screening invitation.
Data were entered in EPIINFO version 6.04 and then
exported to SPSS version 13 for analysis. Crude odds
ratios (ORs) with 95% confidence interval (CI) were calcu-
lated where the women’s screening acceptance comprised
the dependent variable and demographic characteristic
and factors related to the women’s knowledge of cervical
cancer the independent variables. Adjusted analysis was
performed by means of multiple logistic regression, where
the influence of age, marital situation, parity and educa-
tional level were controlled for.
Permission to carry out the study was obtained from
the Tanzania National Institute of Medical Research and
the Danish National Committee on Biomedical Research
Ethics. Verbal informed consent to participate in the study
was obtained from participants. Participants who were
found to have medical problems were assisted to visit the
referral hospital for further management and treatment.
Results
The demographic characteristics of the general popula-
tion together with the demographic characteristics of the
83 women who accepted screening after home visits and
the 721 women who accepted screening after awarenessraising campaigns are summarized in Table 1. Women
who attended screening after home visits or awareness
raising campaigns were more often aged 45–59 (21% and
23%, respectively), were more often married (80% and
78%, respectively) and had more often attended second-
ary school (58% and 33%, respectively) in comparison
with the general population where the corresponding
figures were 12%, 63% and 16%. In addition, the women
who accepted screening after home visits had more often
given birth 5 times or more (39%) than women from the
general population (21%). In contrast, women who
accepted screening after awareness raising campaigns
had more often given birth twice or less (44%) when
compared to the general population (34%).
The associations between screening acceptance and
demographic characteristics are summarized in Table 2.
Women aged 35–44 and women aged 45–59 had
increased ORs of 3.52 and 7.09, respectively, for accepting
the invitation in comparison with women aged 25–34.
Similarly, married women had an increased OR 2.43 for
accepting the screening invitation. Increased ORs for
accepting screening were found among women who had
attended primary or secondary school in comparison with
women who had never attended screening (OR 1.81 and
OR 1.94, respectively). Finally, women who had 0–2 chil-
dren were more prone to accept the invitation in compari-
son with women who had five or more children (OR 3.21).
The 396 women, who in relation to the home visit sta-
ted they had never attended screening, were questioned
about their knowledge of cervical cancer and perceived
barriers for attending health check-ups (Table 3). More
than half (53%) of the women had never heard of cer-
vical cancer. When questioned about perceived barriers
for attending health check-ups, 57% stated that difficult
Table 1 Demographic characteristics of the general population and women who accepted the cervical cancer screening
invitation via the home visit approach and awareness raising campaign
General population N=6063 % Home visits N=83 % Awareness raising N=721 %
Age(years)
25-34 3092 51.0 38 45.8 281 38.9
35-44 2231 36.8 28 33.7 273 37.9
45-59 740 12.2 17 20.5 167 23.1
Marital status
Married 3844 63.4 66 79.5 562 77.9
Single 2219 36.6 17 20.5 159 22.1
Education
No schooling 1158 19.1 6 7.2 43 6.0
Primary school 3923 64.7 29 34.9 442 61.3
Secondary school 982 16.2 48 57.8 236 32.7
No of children
0-2 2061 34.0 8 9.6 316 43.8
3-4 2728 45.0 43 51.8 259 35.9
5+ 1274 21.0 32 38.6 146 20.3
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addition, 31% of the women stated they were reluctant
to go for any test in absence of disease. Lack of medical
advice and fear of being diagnosed as having cancer were
additionally mentioned as a barrier by 12% and 13% of
the women.
Table 4 summarizes the association between screening
acceptance and the women’s knowledge and awareness
of cervical cancer. Awareness of cervical cancer and
screening service were positively associated with screen-




Did not accept scre
invitation N=313
Age(years)
25-34 319 39.7 153
35-44 301 37.4 104
45-59 184 22.9 56
Marital status
Married 628 78.1 214
Single 176 21.9 51
Education
No schooling 49 6.1 35
Primary school 471 58.6 208
Sec. school 284 35.3 70
No of children
0-2 324 40.3 54
3-4 302 37.6 129
5+ 178 22.1 111
*Adjusted for the effect of age, education, marital status and number of children.Similarly, the women’s knowledge of cervical cancer risk
factors was also found to be a determining factor for
screening attendance (ORs of 3.38). Finally, women who
believed that cervical cancer could be prevented and
women who believed screening could improve survival
were also more likely to accept screening with increased
ORs of 10.1 and 10.4, respectively.
Discussion
As cervical cancer screening is being increasingly imple-
mented in developing countries, there is a need towho accepted and who did not accept a cervical cancer
ening
%
Accepted vs. non accepted
Crude OR (95%CI)
Accepted vs. non accepted
Adjusted* OR (95%CI)
48.9 1 1
33.2 1.39 (1.02-1.88) 3.52 (2.37-5.14)
17.9 1.58 (1.09-2.29) 7.09 (4.19-12.3)
68.4 1.18 (0.82-1.84) 2.43 (1.18-2.20)
16.3 1 1
11.2 1 1
66.4 1.62 (0.99-2.63) 1.81 (1.01 - 3.42)
22.4 2.90 (1.69-4.96) 1.94 (1.13 - 4.01)
17.2 3.74 (2.53-5-53) 3.21 (1.71-7.03)
41.2 1.46 (1.05-2.02) 1.08 (0.98-2.71)
35.4 1 1.00
Table 3 Knowledge of cervical cancer and perceived
barriers for attending health check ups among women
who had never attended cervical cancer screening
N=396 Percentage
(%)




Perceived barriers for attending health check-up*
Difficulty in accessing screening services 226 57.1
Lack of health education 34 8.5
Reluctance to go for any test in absence of
disease
123 31.1
Lack of medical advice 46 11.6
Fear of knowing they have cancer 50 12.6
Prohibitive cost of the test 8 2.0
Fear of pain of test 19 4.8
*Add more than 100% since the women were able to respond to more than
one question.
Table 4 Knowledge of cervical cancer screening service amon
cervical cancer screening invitation
Accepted screening
invitation N=83 (%)
Heard about cervical cancer
Yes 68 81.9 1
No/Don’t know 15 18.1 1
Missing 0 3
Heard about screening
Yes 62 74.7 1
No/Don’t know 21 25.3 1
Missing 0 3
Knowledge of cervical cancer risk factors
Yes 38 45.8 6
No/Don’t know 45 54.2 2
Missing 0
Heard of HPV
Yes 4 4.8 1
No/Don’t know 79 95.2 3
Missing 0
Can cervical cancer be prevented
Yes 24 28.9 1
No/Don’t know 59 71.1 2
Missing 0
Can screening improve survival?
Yes 56 67.5 5
No/Don’t know 27 32.5 2
Missing 0
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cancer screening in such settings. The present study is
based on data from Tanzania and reveals that screening
acceptance is associated with being older, being married,
having attended school, and having less than 5 children.
Furthermore, knowledge and awareness of cervical can-
cer and screening benefits seem to have a positive im-
pact on screening acceptance.
This study was designed to include a representative
group of women from a population that had not previ-
ously attended cervical cancer screening and then assess
how they responded to a screening invitation via differ-
ent approaches. Thereby the study has shed light on the
effect of different strategies for inviting women to cer-
vical cancer screening. Home visits lacked efficiency in
improving screening attendance due to its low accept-
ance rate. In contrast, the approach of decentralizing
cervical cancer screening to district level and combining
the decentralization with awareness raising campaigns
was quite effective in making women accepting screen-
ing. Hence, cervical cancer screening attendance may be
enhanced if a move is made from the current centrallyg women who accepted and women who did not accept a
Did not accept screening
invitation N=313 (%)
Accepted vs. non accepted
Crude OR (95%CI)
19 43.4 5.90 (3.1-11.38)
55 56.6 1
9
16 41.3 4.20 (2.35-7.56)
65 58.7 1
2
2 20.0 3.38 (1.96-5.83)
48 80.0 1
3
0 3.2 1.52 (0.39-5.45)
00 96.8 1
3
2 3.9 10.1 (4.55-22.9)
99 96.1 1
2
2 16.6 10.4 (5.82-18.7)
61 83.4 1
0
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tem where the service is offered at a few selected ante-
natal clinics or by mobile out-reach clinics.
The findings from the present study suggests that
older women are more responsive to accept screening
than younger women. A finding which is well in line
with the recommendation that cervical cancer screening
programs should aim at targeting older women since the
benefit from screening this group of women is particu-
larly high. It has for instance been demonstrated that
participation in the UK cervical screening program by
women aged 35–64 reduces the risk of cervical cancer
over the next five years by 60-80% and the risk of
advanced cervical cancer by about 90% [19]. In addition,
the relative protection against cervical cancer is higher
in older women than in women aged 20–34 years [19].
Women of high parity comprised an identifiable sub-
group that was less likely to attend screening in the set-
ting studied. A finding which should raise concern since
the enrolment of high parity women in cervical cancer
screening programs is particularly important given that
high parity is known to be a co-factor of HPV carcino-
genesis via mechanical, hormonal and immunological
mechanisms [20-22]. A possible explanation for the low
screening acceptance among high-parity women may be
that practical barriers such as foregoing domestic activ-
ities are more prevalent among this group of women. To
reach the women most at risk of cervical cancer it is of
paramount importance that reproductive health pro-
grams strive to encourage screening among high parity
women. In that relation it should be stressed that home
visits apparently were more effective than awareness
raising campaigns in making women of high parity at-
tend screening. Educational level did also seem to matter
for women’s screening acceptance. Women who had
attended at least primary school were more likely to at-
tend screening in comparison with women who had
never attended school. These findings are in line with
other studies that have documented that women with
low education are less knowledgeable about the need for
cervical screenings and have limited resources to cater
for their screening attendance due to its inherent cost
[23]. In addressing women’s needs, it should be
acknowledged that many women, in addition to eco-
nomic constraints, counter problems such as long wait-
ing time, cultural deterrents to care and poor quality of
health services when attempting to access screening
services. Attempts should be made to eliminate these
barriers when scaling up cervical cancer screening. In
addition, since wide spread routine use of VIA testing
may be associated with poorer test performance [15,24]
more sensitive, objective and reproducible screening
tests should be considered when scaling up cervical
cancer screening. HPV testing in combination withVIA testing, where the VIA test function as a triage/
treatment activity following HPV testing may be more
appropriate for cervical cancer screening in developing
countries [24]. One of the drawbacks with the inclusion
of HPV as a primary screening method is the asso-
ciated costs. However, with an increasing availability of
simple, affordable, and accurate HPV tests (careHPV
test, Qiagen Gaithersburg, Inc. MD, USA) that provides
results within 3 hours [25] it has been suggested
that cervical cancer screening in low-resource settings
increasingly should be supplemented by HPV testing
[24].
The knowledge and awareness of cervical cancer was
in general low and screening acceptance was associated
with having knowledge of cervical cancer, its risk factors
and, its prevention. Poor knowledge of cervical cancer
has also been found in the more general population of
Tanzania [26]. A number of studies from other sub-
Saharan African countries have similarly found that
women who lack awareness of cervical cancer are less
likely to participate in screening services and are thus at
increased risk of developing cancer [27-29]. In our study
almost half of the women (47%) had never heard the
term cervical cancer. This lack of biomedical knowledge
may partly be explained by the fact that cervical cancer,
despite being the most common female cancer in sub-
Saharan Africa, is a rare condition that has not been
prioritized by the national health system, advocacy
programs have therefore not focused on cervical can-
cer [30]. More diverse strategies should be employed
to convey educational health messages which take into
account the women’s socio economic and cultural
background. In that relation it should be born in
mind that experiences from both developed and devel-
oping countries have shown that conveying message
via word of mouth and via audio visual channels are
effective in making women more aware of cervical
cancer and screening possibilities [31]. In addition,
health education through trained lay persons in com-
munity centers should also be considered as this has
been reported to be an effective method in other
studies [32,33].
In conclusion, we have documented that there are
identifiable subgroups among which cervical cancer
screening can be increased in Dar es Salaam. Special at-
tention should be paid to poorly educated women and
women of high parity. Lack of knowledge of cervical
cancer also contributed in preventing women from
attending cervical cancer screenings. Women’s percep-
tions and notions about cervical cancer need to be fur-
ther assessed to develop communication strategies that
take a broader cultural framework into account. Provid-
ing education and information orally as well as improv-
ing access to more culturally acceptable screening
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services in Tanzania.Competing interests
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